Healthcare Realty Trust Showing Solid Progress on 2.0 Plan, RBC Says

MT newswire2026/10/08 14:56

10:56 AM EDT, 10/08/2026 (MT Newswires) -- Healthcare Realty Trust (HR) is making steady progress on its strategic plan and remains on track to reach its targeted funds-from-operations run-rate ahead of schedule, with recent debt refinancing likely lifting the lower end of that range, RBC Capital Markets said Thursday in a report. Phase I of HR 2.0, focused on fixing systems, is complete, marked by a rebuilt operating team, a workable asset-management model, a stronger balance sheet and clearer audience targeting, RBC said after meeting with company executives. Phase II, centered on execution, is underway as the company deepens its health-system relationships, driving better leasing results and higher tenant retention, the report said. Phase III, aimed at fueling growth, has begun as the company evaluates incremental investment opportunities, the report said. This backdrop supports a three-year FFO run-rate of $1.65 to $1.85, and once achieved, the plan should allow mid-single-digit FFO growth, RBC said. RBC maintained its sector-perform rating on Healthcare Realty stock and its $22 price target. Price: 17.10, Change: +0.22, Percent Change: +1.27

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Bernstein: Huang Renxun's Controversy May Increase Nvidia's Regulatory Risks, but Maintains $400 Price Target

Cointime•2026/11/09 06:43

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37